Facebook
Twitter
LinkedIn
ForwardProject ECHO for Liver Health
This course will only be offered via livestream. **All Livestream meetings are presented in Central Time
This course is only available to Mayo Clinic Personnel
Course Director: Manal F. Abdelmalek, M.D., MPH
October 11 - December 12, 2023
Mayo Clinic Project ECHO™ (Extension for Community Healthcare Outcomes) seeks to be a force multiplier to share academic clinical knowledge with health care providers who practice in rural and underserved areas and want to increase their knowledge of how to identify and treat liver disease. During regularly scheduled ECHO sessions, via Zoom, participants will learn to assess and risk-stratify patients to identify liver disease. Interactive didactics will be presented in the context of “All Teach. All Learn.” CME credit will be awarded to participants, at no cost. Through this model, local providers are trained by academic specialists, higher quality healthcare is delivered locally, disease progression is arrested, steps are made toward health equity to marginalized demographics, and population health outcomes are improved.
Mayo Clinic Project ECHO aims to effectively improve the capacity of clinicians treating liver disease throughout Mayo Clinic Health System to improve patient outcomes. The project is a collaborative model of medical education and care management that helps providers deliver care to patients with chronic liver disease. The project strives to narrow gaps in healthcare disparities for unrepresented minority populations and reduce the burden on the patients by allowing improved access to specialty care.
Why is ECHO Important?
Prevalence of Liver Disease
Liver disease is a significant health concern that is often silent. It is estimated that 35% of the US population suffers from silent liver disease. Liver disease encompasses a range of conditions that affect the liver’s function and structure, including steatotic liver disease (previously known as fatty liver), alcoholic liver disease, viral hepatitis, cirrhosis, liver cancer, and more. If liver disease is diagnosed and addressed early, the consequences can be mitigated, and patient outcomes are much improved.
Target Audience
This course is designed for healthcare providers in the field of family medicine, primary care, internal medicine, gastroenterology and hepatology.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Apply the principles of risk stratification for chronic liver disease in their daily clinical practice.
- Formulate care plans specific to steatotic liver disease.
- Differentiate between at-risk and not at-risk liver disease.
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
Course Director
Manal F. Abdelmalek, M.D.
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 3.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ANCC
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 3.00 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
IPCE
This activity was planned by and for the healthcare team, and learners will receive 3.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
Other Healthcare Professionals:
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
| Date | Title | Credit |
|---|---|---|
| October 11, 2023 7:00 a.m. – 8:00 a.m. | MASLD: What the PCP Needs to Know | 1.00 |
| November 8, 2023 7:00 a.m. – 8:00 a.m. | Treatment of MASLD- Current Approaches | 1.00 |
| December 13, 2023 7:00 a.m. – 8:00 a.m. | Approach to Interpretation of Liver Enzymes | 1.00 |
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Available Credit
- 3.00 AMA PRA Category 1 Credit™
- 3.00 ANCC
- 3.00 Attendance
- 3.00 IPCE
To claim credit for livestream participation in this course, learners must view the content during the hours posted for the live activity. This course is not approved for on-demand delivery.
Commitment to Equity, Diversity and Inclusion
Mayo Clinic School of Continuous Professional Development (MCSCPD) strives to foster a learning environment in which individual differences are valued, allowing all to achieve their fullest potential.
Cancellation and Refund Policy
View Cancellation and Refund Policy
All requests must be submitted in writing using the Contact Us Form.
Any use of this site constitutes your agreement to the Terms and Conditions of Registration.